Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics #00315

Submission Number:
00315
Commenter:
Niravkumar Mehta
State:
Florida
Initiative Name:
Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
Less chance for small businesses to grow . Less competition and monopoly on market. Limitation on patient for getting their scripts. More mail order switches and waste of medications .